At Althea Group Holdings our purpose is to create a thriving ethical business. One that opens customer's and investor's minds to new possibilities, by introducing them to brands with the potential to improve people's lives.
About us
AGH around the globe
-
100+
Global employees
-
4
Continents
-
$24.2b
Estimated addressable pharmaceutical market by 2025*
-
$46.5b
Estimated addressable recreational market by 2025*
Our story.
Latest ASX Announcements
-
Althea THC20 CBD1 Approved For Sale In Ireland
Click here to view -
NHS Reimbursement Achieved for Treatment of Chronic Pain
Click here to view -
Quarterly Activities/Appendix 4C Cash Flow Report
Click here to view
Meet the AGH group
Althea Group Holdings produces some of the cannabis industry's most recognised brands. Servicing both pharmaceutical and recreational cannabis markets, AGH strives to create the best cannabis experience for patients and adult-use consumers alike.
Our businesses
Pharmaceutical cannabis
A global leader in the development, manufacture, sales & distribution of cannabis-based medicines
Visit the website
Recreational cannabis
A leader in the manufacture, sales & distribution of legal recreational cannabis products
Visit the website